Formation of BCR Oligomers Provides a Mechanism for B cell Affinity Discrimination
Philippos K. Tsourkas, Somkanya C. Das, Paul Yu-Yang, Wanli Liu, Susan, K. Pierce, and Subhadip Raychaudhuri

TL;DR
This study uses computational simulations to demonstrate that BCR oligomer formation is a key mechanism for B cell affinity discrimination, aligning with experimental observations of signaling thresholds and kinetics.
Contribution
The paper introduces a novel simulation model showing how BCR oligomerization mediates affinity-dependent signaling in B cells, explaining threshold and ceiling effects.
Findings
BCR oligomer formation increases with antigen affinity
Signaling activity correlates with oligomer size and formation rate
Model predictions match experimental timescales of BCR activation
Abstract
B cells encounter antigen over a wide affinity range. The strength of B cell signaling in response to antigen increases with affinity, a process known as "affinity discrimination". In this work, we use a computational simulation of B cell surface dynamics and signaling to show that affinity discrimination can arise from the formation of BCR oligomers. It is known that BCRs form oligomers upon encountering antigen, and that the size and rate of formation of these oligomers increase with affinity. In our simulation, we have introduced a requirement that only BCR-antigen complexes that are part of an oligomer can engage cytoplasmic signaling molecules such as Src-family kinases. Our simulation shows that as affinity increases, not only does the number of collected antigen increases, but so does signaling activity. Our results are also consistent with the existence of an…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsT-cell and B-cell Immunology · Immune Cell Function and Interaction · Immunotherapy and Immune Responses
